Tag Archives: md anderson

September, 2016

June, 2016

March, 2016

  • 30 March

    Tesaro and MD Anderson Enter Immuno-Oncology Collaboration

    WALTHAM, Mass. and HOUSTON, March 29, 2016 (GLOBE NEWSWIRE) — TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, and the Institute for Applied Cancer Science at The University of Texas MD Anderson Cancer Center today announced an exclusive collaboration to discover and develop small molecule product candidates against undisclosed immuno-oncology targets. …

January, 2016

December, 2015

April, 2015

January, 2015